Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Finch Therapeutics’ C. Difficile drug gets breakthrough status

pharmaceutical-technologyFebruary 13, 2019

Tag: Finch Therapeutics , C. Difficile drug , Microbial therapies , CP101 drug

PharmaSources Customer Service